Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains

References

• Oberste MS, Penaranda S, Maher K, Pallansch MA. Complete genome sequences of all members of the species Human enterovirus A. J Gen Virol. 2004;85:1597–607. doi:10.1099/vir.0.79789-0.
   PubMed Web of Science ®Google Scholar
• Itagaki A, Ishihara J, Mochida K, Ito Y, Saito K, Nishino Y, Koike S, Kurimura T. A clustering outbreak of hand, foot, and mouth disease caused by Coxsackie virus A10. Microbiol Immunol. 1983;27(11):929–35. doi:10.1111/j.1348-0421.1983.tb00658.x
   Google Scholar
• Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, Quak SH, Chow VTK. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14(12):e1076–81. doi:10.1016/j.ijid.2010.07.006.
   PubMed Web of Science ®Google Scholar
• Blomqvist S, Klemola P, Kaijalainen S, Paananen A, Simonen M-L, Vuorinen T, Roivainen M. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virology. 2010;48(1):49–54. doi:10.1016/j.jcv.2010.02.002.
   PubMed Web of Science ®Google Scholar
• Mirand A, Henquell C, Archimbaud C, Ughetto S, Antona D, Bailly JL, Peigue-Lafeuille H. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect. 2012 May;18(5):E110–8. doi:10.1111/j.1469-0691.2012.03789.x
   Google Scholar
• Tseng FC, Huang HC, Chi CY, Lin TL, Liu CC, Jian JW, Hsu L-C, Wu H-S, Yang J-Y, Chang Y-W, et al. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J Med Virol. 2007;79:1850–60. doi:10.1002/jmv.21006.
   PubMed Web of Science ®Google Scholar
• Lo SH, Huang YC, Huang CG, Tsao KC, Li WC, Hsieh YC, Chiu C-H, Lin T-Y. Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect. 2011;44:252–57. doi:10.1016/j.jmii.2011.01.031.
   PubMedGoogle Scholar
• Hoang MTV, Nguyen TA, Tran TT, Vu TTH, Le NTN, Nguyen THN, Le THN, Nguyen TTH, Nguyen TH, Le NTN, et al. Clinical and aetiological study of hand, foot and mouth disease in southern Vietnam, 2013–2015: inpatients and outpatients. Int J Infect Dis. 2019;80:1–9. doi:10.1016/j.ijid.2018.12.004.
   PubMed Web of Science ®Google Scholar
• Nhan LNT, Khanh TH, Hong NTT, Van HMT, Nhu LNT, Ny NTH, Nguyet LA, Thanh TT, Anh NT, Hang VTT, et al. Clinical, etiological and epidemiological investigations of hand, foot and mouth disease in southern Vietnam during 2015-2018. PLoS Negl Trop Dis. 2020;14:e0008544. doi:10.1371/journal.pntd.0008544.
   PubMed Web of Science ®Google Scholar
• Nhan LNT, Turner HC, Khanh TH, Hung NT, Lien LB, Hong NTT, Nhu LNT, Ny NTH, Nguyet LA, Thanh TT, et al. Economic burden attributed to children presenting to hospitals with hand, foot, and mouth disease in Vietnam. Open Forum Infect Dis. 2019;6. doi:10.1093/ofid/ofz284
   Web of Science ®Google Scholar
• Witso E, Palacios G, Cinek O, Stene LC, Grinde B, Janowitz D, Lipkin WI, Rønningen KS. High prevalence of human enterovirus a infections in natural circulation of human enteroviruses. J Clin Microbiol. 2006;44(11):4095–100. doi:10.1128/JCM.00653-06.
   PubMed Web of Science ®Google Scholar
• Chatproedprai S, Theanboonlers A, Korkong S, Thongmee C, Wananukul S, Poovorawan Y. Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008-2009. Jpn J Infect Dis. 2010 Jul;63(4):229–33
   PubMed Web of Science ®Google Scholar
• Linsuwanon P, Puenpa J, Huang SW, Wang YF, Mauleekoonphairoj J, Wang JR, Poovorawan Y. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J Biomed Sci. 2014 Feb 18;21(1):16. doi:10.1186/1423-0127-21-16
   Google Scholar
• Puenpa J, Mauleekoonphairoj J, Linsuwanon P, Suwannakarn K, Chieochansin T, Korkong S, Theamboonlers A, Poovorawan Y. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One. 2014 Jun 2;9(6):e98888. doi:10.1371/journal.pone.0098888
   Google Scholar
• Gopalkrishna V, Patil PR, Patil GP, Chitambar SD. Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol. 2012;61:420–25. doi:10.1099/jmm.0.036400-0.
   PubMed Web of Science ®Google Scholar
• Davia JL, Bel PH, Ninet VZ, Bracho MA, Gonzalez-Candelas F, Salazar A, Gobernado M, Bosch IF. Onychomadesis outbreak in Valencia, Spain associated with hand, foot, and mouth disease caused by enteroviruses. Pediatr Dermatol. 2011;28:1–5. doi:10.1111/j.1525-1470.2010.01161.x.
   PubMed Web of Science ®Google Scholar
• He YQ, Chen L, Xu WB, Yang H, Wang HZ, Zong WP, Xian H-X, Chen H-L, Yao X-J, Hu Z-L, et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol. 2013;51:3560–66. doi:10.1128/JCM.01231-13.
   PubMed Web of Science ®Google Scholar
• He SZ, Chen MY, Xu XR, Yan Q, Niu JJ, Wu WH, Su XS, Ge SX, Zhang SY, Xia NS, et al. Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015. Epidemiol Infect. 2017;145:1865–74. doi:10.1017/S0950268817000309.
   PubMed Web of Science ®Google Scholar
• Mao Q-Y, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016;15(5):599–606. doi:10.1586/14760584.2016.1138862.
   PubMed Web of Science ®Google Scholar
• Yang Q, Ding J, Cao J, Huang Q, Hong C, Yang B. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10. J Med Virol. 2015;87:954–60. doi:10.1002/jmv.24151.
   PubMed Web of Science ®Google Scholar
• Tian H, Zhang Y, Shi Y, Li X, Sun Q, Liu L, Zhao D, Xu B. Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China, 2009-2012. PLoS One. 2017;12:e0176604. doi:10.1371/journal.pone.0176604.
   PubMed Web of Science ®Google Scholar
• Chen M, He S, Yan Q, Xu X, Wu W, Ge S, Zhang S, Chen M, Xia N. Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015. J Clin Virol. 2017;93:20–24. doi:10.1016/j.jcv.2017.05.011.
   PubMed Web of Science ®Google Scholar
• Ji H, Fan H, Lu PX, Zhang XF, Ai J, Shi C, Huo X, Bao C-J, Shan J, Jin Y, et al. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infect Dis. 2019;19:79. doi:10.1186/s12879-018-3659-7.
   PubMed Web of Science ®Google Scholar
• Reed L, Muench H. A simple, method of estimating 50 percent end point. American Journal of Hygiene. 1938; 27, 493–497
   Google Scholar
• Lu QB, Zhang XA, Wo Y, Xu HM, Li XJ, Wang XJ, Ding S-J, Chen X-D, He C, Liu L-J, et al. Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. PLoS One. 2012;7:e52073. doi:10.1371/journal.pone.0052073.
   PubMed Web of Science ®Google Scholar
• Tian H, Zhang Y, Sun Q, Zhu S, Li X, Pan Z, Xu W, Xu B. Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3. PLoS One. 2014;9(1):e84233. doi:10.1371/journal.pone.0084233.
   PubMed Web of Science ®Google Scholar
• Nguyen AT, Tran TT, Hoang VM, Nghiem NM, Le NN, Le TT, Phan QT, Truong KH, Le NNT, Ho VL, et al. Development and evaluation of a non-ribosomal random PCR and next-generation sequencing based assay for detection and sequencing of hand, foot and mouth disease pathogens. Virol J. 2016;13(1):125. doi:10.1186/s12985-016-0580-9.
   PubMed Web of Science ®Google Scholar
• Hoa-Tran TN, Nguyen AT, Dao ATH, Kataoka C, Ta HTT, Nguyen HTV, Takemura T, Nguyen TTT, Vu HM, Nguyen TTH, et al. Genetic characterization of VP1 of coxsackieviruses A2, A4, and A10 associated with hand, foot, and mouth disease in Vietnam in 2012-2017: endemic circulation and emergence of new HFMD-causing lineages. Arch Virol. 2020;165:823–34. doi:10.1007/s00705-020-04536-3.
   PubMed Web of Science ®Google Scholar
• Ji T, Guo Y, Huang W, Shi Y, Xu Y, Tong W, Yao W, Tan Z, Zeng H, Ma J, et al. The emerging sub-genotype C2 of CoxsackievirusA10 associated with hand, foot and mouth disease extensively circulating in mainland of China. Sci Rep. 2018;8(1):13357. doi:10.1038/s41598-018-31616-x.
   PubMed Web of Science ®Google Scholar
• Gao W, Yue L, Yang T, Li H, Song X, Xie T, He X, Xie Z. A comparative study on biological characteristics of ten coxsackievirus A10 virus strains. Virology. 2021;555:1–9. doi:10.1016/j.virol.2020.07.003.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang C, Liu Q, Gong S, Geng L, Huang Z. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection. Antiviral Res. 2018;152:124–30. doi:10.1016/j.antiviral.2018.02.016.
   PubMed Web of Science ®Google Scholar
• Shen C, Liu Q, Zhou Y, Ku Z, Wang L, Lan K, Ye X, Huang Z. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge. Vaccine. 2016;34:5005–12. doi:10.1016/j.vaccine.2016.08.033.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dong Z, Wang Q, Carr MJ, Li J, Liu T, Li D, Shi W. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice. Vaccine. 2018;36(46):7095–104. doi:10.1016/j.vaccine.2018.09.069.
   PubMed Web of Science ®Google Scholar
• Lim H, In HJ, Lee JA, Sik Yoo J, Lee SW, Chung GT, Choi YK, Chung JK, Cho SJ, Lee J-W, et al. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease. Vaccine. 2018;36:3445–52. doi:10.1016/j.vaccine.2018.05.005.
   PubMed Web of Science ®Google Scholar
• Zhang W, Dai W, Zhang C, Zhou Y, Xiong P, Wang S, Ye X, Liu Q, Zhou D, Huang Z, et al. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerg Microbes Infect. 2018;7:94. doi:10.1038/s41426-018-0094-1.
   PubMed Web of Science ®Google Scholar
• Mao Q, Li N, Yu X, Yao X, Li F, Lu F, Zhuang H, Liang Z, Wang J. Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol. 2012;157:37–41. doi:10.1007/s00705-011-1136-3.
   PubMed Web of Science ®Google Scholar
• Gz MAOQY, Cs HAO, YU D, Gao F, Ch DONG, WQ AN, Gao Q, ZP XIE, Xl LI, ZL LIANG. Screening and preparation of candidate standard strain for determination of neutralizing antibody against enterovirus 71. Chin J Biologicals. 2012;25:725–29.
   Google Scholar
• Sun S, Gao F, Mao Q, Shao J, Jiang L, Liu D, Wang Y, Yao X, Wu X, Sun B, et al. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice. Hum Vaccin Immunother. 2015;11(10):2406–13. doi:10.1080/21645515.2015.1053675.
   PubMed Web of Science ®Google Scholar
• Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, Su IJ. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci. 2000 Nov-Dec;7(6):523–8. doi:10.1007/BF02253368
   Google Scholar
• Mizuta K, Aokia Y, Sutoa A, Ootani K, Katsushima N, Itagaki T, Ohmi A, Okamoto M, Nishimura H, Matsuzaki Y, et al. Cross-antigenicity among EV71 Ss from different genogroups isolated in Yamagata, Japan, between 1990 and 2007[J]. Vaccine. 2009;27:3153–58. doi:10.1016/j.vaccine.2009.03.060.
   PubMed Web of Science ®Google Scholar
• Zhang H, An D, Liu W, Mao Q, Jin J, Xu L, Sun S, Jiang L, Li X, Shao J, et al. Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay. PLoS One. 2014 25;9(6):e100545. doi: 10.1371/journal.pone.0100545. eCollection 2014
   PubMed Web of Science ®Google Scholar
• Liu P, Yuan YD, Cui BP, Huo Y, Bian L, Chen L, Liu S, Wang C, Xu Y, Tedcastle A, et al. Cross-antigenicity between EV71 sub-genotypes: implications for vaccine efficacy. Viruses. 2021;13(5):720. doi:10.3390/v13050720.
   PubMed Web of Science ®Google Scholar